That 30% "haircut",  whether devestatating or not for Biogen.....I'm suggesting that if BETonMACE were to fail with respect to the Primary Outcome....I'm suggesting 30% is nowhere near what would happen to Resverlogix, imo we'd see the Mcap drop by 90+% here.

At this point its is entirely moot....we don't know if BETonMACE will achieve its primary endpoint or not.  Hopefully the question remains forever academic and we never find out what would happen to RVX's PPS and marketcap if BETonMACE failed and was forced to go back to the drawing board.